μεεϊψιν 1000
|
ων δϊψετδ αΰπβμιϊ: Levetrim 1000.
ξητωιν ϊψετδ ΰηψϊ? λπρε μΰιπγχρ δϊψετεϊ »
|
|
 αρμ δαψιΰεϊ
φεψϊ ξϊο
PER OS
ξιπεο
Film Coated Tablets
ωιξεω αϊψετδ
- Levetrim is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetrim is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - Levetrim is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - Levetrim is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
ξρτψ ψιωεν
143 77 31941 00
ιφψο
Trima Israel Pharmaceutical Products Maabarot Ltd, Israel
ηεξψ τςιμ
|
ψιλεζ / λξεϊ αιηιγϊ ξιπεο
|
Levetiracetam |
1000 MG |
ΰψιζδ
|
λξεϊ αΰψιζδ
|
ηιι ξγσ
|
ϊψετϊ ξψων
|
Blister pvc/aluminium |
60 x TABLETS |
ηεγωιν 36 |
λο |
Blister pvc/aluminium |
10 x TABLETS |
ηεγωιν 36 |
λο |
|
|
|